Related Experiment Video
Updated: Jan 26, 2026

Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells
Published on: January 17, 2019
Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2
Julien Cherfils-Vicini1, Charlene Iltis1, Ludovic Cervera1
1Université Côte d'Azur, Centre National de la Recherche Scientifique (CNRS) UMR7284, Institut National de la Santé et de la Recherche Médicale (INSERM) U1081, Institute for Research on Cancer and Aging, Nice (IRCAN), Nice, France.
Abstract:
Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells with strong immunosuppressive activity that promote tumor growth. In this study, we describe a mechanism by which cancer cells control MDSCs in human cancers by upregulating TRF2, a protein required for telomere stability. Specifically, we showed that the TRF2 upregulation in cancer cells has extratelomeric roles in activating the expression of a network of genes involved in the biosynthesis of heparan sulfate proteoglycan, leading to profound changes in glycocalyx length and stiffness, as revealed by atomic force microscopy. This TRF2-dependent regulation facilitated the recruitment of MDSCs, their activation via the TLR2/MyD88/IL-6/STAT3 pathway leading to the inhibition of natural killer recruitment and cytotoxicity, and ultimately tumor progression and metastasis. The clinical relevance of these findings is supported by our analysis of cancer cohorts, which showed a correlation between high TRF2 expression and MDSC infiltration, which was inversely correlated with overall patient survival.
Insights
Cancer cells upregulate TRF2 to boost immunosuppressive myeloid-derived suppressor cells (MDSCs), promoting tumor growth. This TRF2 mechanism involves altering the cell surface, enhancing MDSC recruitment and activity, and hindering anti-tumor immunity.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Myeloid-derived suppressor cells (MDSCs) are key immunosuppressors in the tumor microenvironment.
- Tumor progression relies on mechanisms that promote MDSC accumulation and function.
Purpose of the Study:
- To elucidate the role of TRF2 in cancer-mediated MDSC regulation.
- To investigate the molecular pathways linking cancer cells, TRF2, and MDSC activity.
Main Methods:
- Analysis of TRF2 expression in cancer cells and its impact on gene expression.
- Assessment of glycocalyx changes using atomic force microscopy.
- Investigation of signaling pathways (TLR2/MyD88/IL-6/STAT3) involved in MDSC activation.
- Correlation analysis with clinical cancer patient data.
Main Results:
- Cancer cell TRF2 upregulation activates heparan sulfate proteoglycan biosynthesis genes, altering cell surface properties.
- TRF2-induced changes facilitate MDSC recruitment and activation via the TLR2/MyD88/IL-6/STAT3 pathway.
- This process inhibits natural killer cell cytotoxicity, promoting tumor progression and metastasis.
- High TRF2 expression correlates with increased MDSC infiltration and reduced patient survival.
Conclusions:
- TRF2 plays a critical extratelomeric role in cancer by modulating the tumor microenvironment through MDSC manipulation.
- Targeting TRF2 or its downstream pathways may offer novel therapeutic strategies for cancer treatment.
- TRF2 serves as a potential biomarker for predicting patient prognosis and MDSC infiltration.
Related Concept Videos
Telomeres and Telomerase
Telomeres and Telomerase
Glycocalyx and its Functions
Escape Velocity
To calculate the escape velocity, it is assumed that no energy is lost to any frictional forces. In practice, a satellite...
Escape Velocities of Gases
What is the Immune System?

